残存腎機能の喪失の臨床試験
合計1830件
-
Vasopharm GmbHWinicker Norimed GmbH完了
-
University of California, San Diego完了
-
University of PittsburghC. R. Bard完了急性腎障害 | Intensive Monitoring of Renal Function
-
Novartis Pharmaceuticals終了しました腎機能障害を伴う転移性がん | 腎機能は正常な転移性がんベルギー
-
Astellas Pharma Global Development, Inc.完了
-
Centre Hospitalier Departemental Vendee募集
-
Iuliu Hatieganu University of Medicine and Pharmacyわからない術後の残存キュラリゼーションの発生率
-
Endeavor Biomedicines, Inc.積極的、募集していない
-
Tufts UniversityBoston University; Boston Medical Center; Hebrew SeniorLife完了
-
Unity Health Toronto完了Real Function Post Conversion From Prograf to Advagraf | Examin Ethnicity and Pharmacogenetics of the Cohort Requiring Dose Adjustment Post-conversionカナダ
-
Northumbria University完了
-
Mitsubishi Tanabe Pharma America Inc.完了
-
Assistance Publique - Hôpitaux de Parisまだ募集していません
-
Brigham and Women's HospitalNational Heart, Lung, and Blood Institute (NHLBI)完了
-
Chiesi Farmaceutici S.p.A.引きこもった
-
University Hospital, Basel, Switzerland募集
-
University of Illinois at Urbana-Champaign完了
-
Wageningen UniversityTop Institute Food and Nutrition完了高血圧症 | 血圧 | 血管機能 | 腎機能オランダ
-
Washington University School of MedicineSt. Louis Jewish Community Center; St. Louis Naturally Occurring Retirement Community (NORC)完了
-
Haukeland University HospitalOslo University Hospital完了
-
University of ChileNational Fund for Research and Development in Health, Chile; Fondo Nacional de Desarrollo Científico...完了